Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Combination Chemotherapy in Advanced CRC (CAIRO)
NCT00312000Phase 3Completed
- Sponsor
- Dutch Colorectal Cancer Group
- Start
- Jan 2003
- Primary completion
- Feb 2006
- Modality
- Nanoparticles, Monoclonal Antibodies, DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of capecitabine, irinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumab, oxaliplatin in colorectal cancer (CRC), sponsored by Dutch Colorectal Cancer Group. Started Jan 2003; status: completed.
02
Drugs
capecitabineirinotecan hydrochloride liposome injection (II) + temozolomide + bevacizumaboxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00312000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312000.